Krystal Biotech buy Chardan Capital
Start price
05.08.25
/
50%
€118.80
Target price
05.08.26
€189.46
Performance (%)
14.69%
Price
22:26
€136.25
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 14.69%. This prediction currently runs until 05.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 10.983% | 10.983% |
| iShares Core DAX® | -0.819% | -4.026% |
| iShares Nasdaq 100 | 0.462% | 1.068% |
| iShares Nikkei 225® | 1.004% | 2.049% |
| iShares S&P 500 | 0.008% | 1.360% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat